Hydrochloric Acid → HCID 86734704, compound
Reaction equation
[CH3:1][C@H:2]([OH:10])[C@@H:3]([OH:9])[C@@H:4]([NH2:8])[CH2:5][CH:6]=[O:7].FC(F)(F)C([O:15][C:16](=[O:21])[C:17]([F:20])([F:19])[F:18])=O.[ClH:24]>C(OCC)C>[Cl:24][C@:6]1([O:10][C@@H:2]([CH3:1])[C@@:3]([O:15][C:16](=[O:21])[C:17]([F:18])([F:19])[F:20])([OH:9])[C@@H:4]([NH:8][C:16](=[O:15])[C:17]([F:20])([F:19])[F:18])[CH2:5]1)[OH:7]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
One gram of daunosamine (II) hydrochloride was suspended in anhydrous diethyl ether and treated at 0° C. with 8 ml. of trifluoroacetic anhydride. After allowing the suspension to stand for two hours at 0° C. and one hour at room temperature, the solvent was removed under reduced pressure and the residue was crystallized from dichloromethane to yield 1.1 g. of 2,3,6-trideoxy-1-trifluoroacetoxy-3-trifluoroacetamido-4-trifluoroacetoxy-L-lyxopyranose (IIA), having a m.p. of 132°-134° C. and a mass spectrum m/e 391 (M-44), 322 (M-113). 0.5 g of (IIA) in anhydrous diethyl ether was treated at 0° C. with anhydrous gaseous hydrogen chloride. After standing at +5° C. overnight, the solvent was removed in vacuo to yield 1-chloro-2,3,6-trideoxy-3-trifluoroacetamido-4-trifluoroacetoxy-α-L-lyxohexopyranose (IIB) as crystalline product. The NMR spectrum of (IIB) in CDCl3 was as follows:
Workup
- additiontreated at 0° C. with 8 ml
- customthe solvent was removed under reduced pressure
- customthe residue was crystallized from dichloromethane
- customto yield 1.1 g
- waitAfter standing at +5° C. overnight
- customthe solvent was removed in vacuo
Sources & evidence
- ORD record
- ord-65073ca80bd44274a9ea7d38df0aa284
- Source dataset
- uspto-grants-1978_07
- Patent number
- US04098798
Reaction notes
Loading…